Clinical Trials Logo

Filter by:
NCT ID: NCT04537247 Recruiting - Renal Tumor Clinical Trials

A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

To compare safety and efficacy between open and robotic partial nephrectomy in treatment of organ confined complex renal tumors (R.E.N.A.L score more than 7) as regarding surgical results, morbidity, clinical as well as oncological and functional outcomes.

NCT ID: NCT04537169 Recruiting - Congenital Ptosis Clinical Trials

Clinical Significance of Whitnall Ligament Structure

Start date: August 20, 2020
Phase:
Study type: Observational

Prospective clincal study to relate the structure of Whitnall ligament in cases of congenital ptosis to the severety of ptosis and the postoperative results.

NCT ID: NCT04536389 Recruiting - Clinical trials for Intracytoplasmic Sperm Injection ,Hysteroscopicaly Detected Cervical Pathologies

Pregnancy Rates in Women With Normal Uterine Cavity With and Without Cervical Abnormalities

Start date: October 1, 2018
Phase:
Study type: Observational

The aim of our study is to investigate the pregnancy rates in women with normal uterine cavity ,with and without cervical abnormalities.

NCT ID: NCT04536207 Recruiting - Cancer Clinical Trials

Cryotherapy for Neuropathy in Children

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children

NCT ID: NCT04535869 Recruiting - COVID-19 Clinical Trials

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)

CCOVID-19
Start date: December 28, 2020
Phase: Phase 3
Study type: Interventional

COVID 19 which started from a zoonotic transmission related to crowded markets was confirmed to have a high potential for transmission to close contacts on 20 January 2020 by the National Health Commission of China and it was announced as a pandemic by the WHO on 11 March 2020. There is currently no clinically proven specific antiviral agent available for SARS-CoV-2 infection. Supportive treatment, including oxygen therapy, conservation fluid management, and broad-spectrum antibiotics to cover secondary bacterial infection, remains the most important management strategy. Interestingly, sofosbuvir has recently been proposed as an antiviral for the SARS-CoV-2 based on the similarity between the replication mechanisms of the HCV and the coronaviruses. Aim of our study is to assess the safety and efficacy of of the addition of HCV treatment to the standard regimen for the treatment of patients according to MOHP protocol.

NCT ID: NCT04532255 Recruiting - Clinical trials for Periodontal Diseases

Periodontal Health Knowledge Among Patients With Fixed Orthodontic Appliance

Start date: October 2020
Phase:
Study type: Observational

The study is a cross-sectional survey investigating the Periodontal health knowledge among patients with fixed orthodontic appliance attending the orthodontic department and the paid section faculty of dentistry Cairo University. The faculty of Dentistry, Cairo University is an open public facility, a tertiary healthcare and a referral center.

NCT ID: NCT04531371 Recruiting - Clinical trials for Postoperative Confusion

Magnesium Sulphate, Dexemeditomedine and Emergency Agitation

agitation
Start date: June 1, 2020
Phase: Phase 1
Study type: Interventional

Emergence agitation is a postanesthetic phenomenon that develops in the early phase of general anesthesia recovery, and is characterized by agitation, confusion, disorientation, and possible violent behavior. Though agitation is observed more frequently in pediatric patients, the incidence in adults has been reported at 4.7% or 21.3%. Emergence agitation can lead to serious consequences such as self-extubation, removal of catheters, hemorrhage, and even severe injuries from falling out of the bed. Furthermore, it may increase the demand on human resources and cause medical staff injuries.

NCT ID: NCT04531332 Recruiting - Pneumonia Clinical Trials

Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia

Start date: November 15, 2019
Phase: N/A
Study type: Interventional

The investigator's goal in this study is to determine the clinical efficacy and safety of continuous infusion in comparison with standard intermittent infusion.

NCT ID: NCT04531215 Recruiting - Analgesia Clinical Trials

Ultrasound Guided Retrolaminar Versus Erector Spinae Plane Block for Postoperative Analgesia

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Thoracic epidural anesthesia (TEA) and paravertebral block (PVB) have been utilized to give perioperative regional anesthesia in the trunk. TEA is technically troublesome in some cases, and is associated with a danger of serious complications, such as epidural hematoma, nerve injury, and hypotension. PVB has the benefit of perception of the needle position using ultrasonography. However, PVB is also additionally connected with a danger of serious complications, such as pneumothorax, hypotension, or nerve injury. Newer approaches to deal with PVB have been the focal point of numerous techniques lately; these methodologies incorporate retrolaminar block (RLB) and erector spinae plane block (ESPB)

NCT ID: NCT04531111 Recruiting - Covid19 Clinical Trials

Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt

Start date: July 7, 2020
Phase:
Study type: Observational

During the current unusual situation with COVID-19 pandemic and the lockdown applied in most of the countries, school students were kept at home and offered e-learning modules and all activities were suspended. Lockdown entails significant modifications of life style, involving changes in physical activities, dietary habits and nutrition, which are likely to impact glycemic control. So the aim of the current study is to evaluate the impact of COVID-19 pandemic on glycemic control among children and adolescents with type 1 diabetes.